20MP.F MOUNTAIN VALLEY MD HLDGS

Healthcare Pharmaceuticals Frankfurt Exchange
0.0380 EUR
Close of Aug 22, 2026
0.0002 0.0520
Market cap
EUR 13.4M
P/E
-
P/B
12.45x
ROE
-358.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 20MP.F undervalued?

Graham number

The Graham number of MOUNTAIN VALLEY MD HLDGS cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MOUNTAIN VALLEY MD HLDGS fundamental analysis

No fundamental analysis for MOUNTAIN VALLEY MD HLDGS yet.

MOUNTAIN VALLEY MD HLDGS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MOUNTAIN VALLEY MD HLDGS

The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant s…

Full company profile